1. Diabetes drug makers slapped with $9 billion penalty

    Court hits Big Pharma with $9 billion haymaker

    Listen, I've heard that men are from Mars and women are from Venus. But I've spent most of my adult life trying to figure out which language these slimy drug company execs are speaking.

    They always seem to be talking Martian -- and when they do, it gets my Mercury rising fast.

    But it looks like a Louisiana jury has finally cracked the code. Because they're sending two of the largest, dirtiest drug companies on the block a loud message you'd understand in any language.

    They're slapping 'em right in the wallet. A federal court has just fined Takeda Pharmaceuticals and Eli Lilly $9 BILLION for allegedly lying and withholding data proving that their diabetes drug Actos causes bladder cancer.

    This wasn't some slap on the wrist, either -- it was a punch in the gut. This is more than THREE TIMES what the Libyan government paid to victims after it blew up Pan Am Flight 103. And it represents two full years of Eli Lilly's profits.

    The only shame is that we couldn't make these heartless, drug-pushing hooligans pay more.

    You see, the FDA warned in 2011 that Actos could boost your bladder cancer risk 40%, but "only" if you took it for longer than a year. Well, that covers just about everybody. Ever heard of a diabetes drug you only take for a year?

    And you'll have to excuse Takeda and Eli Lilly if they weren't exactly floored by the news. According to a whistleblower who came forward during the trial, Takeda knowingly withheld information that linked Actos to cancer. These greedy pigs were hell-bent on getting FDA approval, even if it killed you.

    Well, as my mother always said, only a fool gets tricked twice. If you're taking Cialis, Prozac, Prevacid, or any other product made by Eli Lilly and Takeda, talk to your doc about ditching them forever. Because what we know about these drugs is terrifying -- but what we don't know may be even worse.

    Your backstage pass to Big Pharma's dirty dealings,

  2. Actos maker sued over cancer link

    Actos was supposed to be the "safer" alternative to Avandia, the diabetes drug that boosted heart risk so much that it was ultimately pulled from pharmacies.

    In reality, Actos might actually be just as bad for your heart. And even if you manage to survive that risk, you could find yourself in a life-or-death battle with bladder cancer.

    Some alternative!

    Now, Takeda Pharmaceuticals -- the company that makes the drug -- is bracing itself for some 10,000 lawsuits after a study this year found the med can actually increase the risk of bladder cancer by up to 40 percent.

    The news caused France and Germany to pull the drug from the market -- but naturally, the FDA did no such thing. Instead, the agency took just about the weakest action possible: It ordered the company to tweak the fine print on the warning label.

    And that means, as usual, the only one who can protect you is you.

    If you've already made the jump from Avandia to Actos, don't even waste your time looking for your next "safe" landing spot.

    You won't find it.

    Actos, Avandia and the rest of them aren't cures -- they exist only to "manage" the disease, and if you keep taking them you'll manage yourself right into the grave.

    There's just one way to beat diabetes, and that's with the lifestyle changes that would have prevented it in the first place: Give up sugar, give up carbs and get your life back.

    It really is that simple. But if you need a boost, look up benfotiamine. It's a synthetic form of thiamine so powerful it can actually undo years of diabetes damage.

  3. Frightening new questions over Actos

    ...the main drug being foisted on former Avandia patients (the ones still living anyway) has now been linked AGAIN to an increased risk of bladder cancer.
  4. Researchers confirm Avandia risk

    Researchers say Avandia can up your risk of heart attack, heart failure, and an early death.
  5. Drugs for diabetes prevention

    With all the hoopla over the diabetes drug Avandia lately, its major competitor -- Actos -- is being handed the golden ticket.
  6. New rules only apply to new patients

    If you've got one foot in the grave already thanks to Avandia, the feds want to give you a little shove to help finish the job.

6 Item(s)